Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: Made by Bayer AG and Onyx Pharmaceuticals Inc, Nexavar is  approved in the United States for kidney and liver cancer. Eight out of the first nine patients who took the drug saw  improvements in their ability to exercise, and six out of nine  had significant improvement in their right ventricular ejection  fraction, which measures the heart’s ability to pump blood to  the lungs. Four patients had decreased pressure in their pulmonary  artery, which supplies blood to the lungs. “What patients are telling us is they are able to do more  in their daily lives,” said Dr. Mardi Gomberg-Maitland of the  University of Chicago, who presented her findings at a meeting  of the American Thoracic Society in Toronto. The original  research on the drug was done at the University. She said the surprising thing is that the drug worked so  quickly. Patients saw benefits in only four months. The study is the first human trial to examine the  sorafenib, or Nexavar, in pulmonary hypertension, a disease in  which blood vessels feeding the lungs narrow, forcing the heart  to work harder. Like cancer, pulmonary hypertension is a disease marked by  abnormal cell growth, which narrows the arteries feeding the  lungs, reducing blood flow and taxing the heart. Sorafenib  appears to interfere with this process. The trial enrolled patients with stable disease who  continued to take their primary medications, which included a  continuous infusion of a drug called prostacyclin and Pfizer  Inc’s Viagra or sildenafil. Both relax blood vessels that feed  the lungs. Gomberg-Maitland said this therapy typically slows  progression of the disease, but does not reverse it. They added sorafenib for 16 weeks, but at a lower dose than  cancer patients use. Most patients in the trial increased their exercise  capacity, as measured by time on a treadmill or a six-minute  walk test. They saw an average 8 percent improvement in their  right ventricular ejection fraction, a measure of the heart’s  pumping power. Side effects included mild hair loss and skin reactions. The study was designed to last only 16 weeks, but all of  the patients continue to take the drug, some now for more than  a year. “What is exciting about this is all of the patients feel  better and nobody wants to come off the medication,”  Gomberg-Maitland said in a telephone interview. The study was intended to test the safety and dosing of the  drug. It was funded by The Doris Duke Foundation and the  University of Chicago. The researchers now plan to study the drug in 40 to 60  patients at different research centers. Claim: Nexavar helped in pulmonary hypertension study.
[A]: The cancer drug Nexavar is showed  promise in a small study of people with pulmonary hypertension,  a debilitating condition marked by high blood pressure in the  arteries that supply the lungs, U.S. researchers said on  Monday.


[Q]: Paragraph: The Korea Centers for Disease Control and Prevention (KCDC) said there were 47 new infections as of midnight on Sunday compared with 81 recorded a day earlier, taking the national tally to 10,284. The death toll rose by eight to 191, while another 135 people have recovered from the virus for a total of 6,598. South Korea has been bringing the epidemic under control, with about 100 or fewer new daily cases for the past month, but this was the first time the daily tally of new cases was less than 50 since 909 were reported on Feb. 29. In February, South Korea uncovered what was believed to be the biggest outbreak outside of China. But a programme of mass testing and contact tracing helped contain the virus, which has spread far more quickly in other countries. The head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, held a 25-minute phone call with President Moon Jae-in, praising South Korea’s leadership in containing the virus, Moon’s presidential Blue House said. Moon said in the call that South Korea was “willing to actively support other countries with prevention skills and supplies as the circumstances permit”. Moon said he recently had phone calls with about 20 global leaders. Tedros proposed that Moon help support sub-Saharan African countries with virus-related supplies including test kits, the Blue House said. Despite the encouraging evidence in South Korea, officials have urged even greater vigilance, saying a large epidemic could re-emerge at any time, with smaller outbreaks appearing in churches, hospitals and nursing homes, as well as among travellers returning from abroad. “We are taking great caution against any optimistic expectations with this one-off figure,” Vice Health Minister Kim Gang-lip told a regular briefing. Click here for an interactive graphic tracking the global spread of coronavirus  On Saturday, the government extended its intensive social distancing campaign by two weeks, citing the sustained small clusters of infections. South Koreans had refrained from socialising in February when the number of cases rose exponentially but more people started going out recently as the weather became warmer and people became weary of the isolation, Kim said. The movement of people spiked about 20% over the weekend compared with the end of February, he said, citing data from the state-run statistics agency and SK Telecom, the country’s largest mobile operator. Starting on Sunday, the government toughened penalties for those who violate self-quarantine rules to up to 10 million won ($8,100) in fines or one year in prison from 3 million won  ($2,400) in fines. Authorities have reported several cases of quarantine rules being broken over the past few days. The Gunpo city government south of Seoul said on Sunday it has filed a complaint with police against a couple in their 50s and their children who broke away from isolation and went out even after testing positive for the virus. A Korean student living in the United States sparked public uproar after taking a fever remedy before flying home late last month. The student was found to have contracted the virus, putting some 20 other people who took the same flight in self quarantine. “We cannot maintain social distancing forever,” Kim said. “But it is the most effective measure to help protect others and yourself.” Claim: South Korea reports fewer than 50 new infections, earning WHO praise.
[A]: South Korea reported fewer than 50 new coronavirus cases for the first time since its peak in late February, earning the praise of the World Health Organization for combatting the spread in one of the first countries to be hard-hit by the disease.


[Q]: Paragraph: After about a 45-minute outpatient procedure and a bill ranging from $3,500 to $7,500, New York-based Antell’s patients emerge with what he said is a confidence boost: an athletic, youthful look from a more prominent chin. “People want that leading lady, leading man look,” said Antell, who is also an assistant clinical professor of surgery at Columbia University. “If you look at people in the limelight, they all have strong chins and it’s a part of the profile that has long been overlooked,” he said. Chin implants surged by 71 percent in 2011 as more than 20,600 adults went under the knife to sharpen their jaw lines, up from roughly 12,000 the year before, according to the American Society of Plastic Surgeons. Strong chins are associated with leadership, confidence and honesty, Antell said, not to mention some powerful men and women. “Romney’s got a great chin,” Antell said of the presidential hopeful. “Obama has a pretty good chin. Bill Clinton has a very good chin.”   Chin implants surgery increased more than breast augmentation, Botox and liposuction combined last year with both men and women opting for the procedure in nearly equal numbers, according to the American Society of Plastic Surgeons. Chin augmentation, or actually making the chin protrude more, increased among all patients over the age of 20, with the most significant increases in patients 40 and older, according to the society. Facial aging tends to appear first on the chin and jaw line and surgery provides a quick change, experts said. They also point to video chat and online photo technology as driving forces behind the escalating numbers. Posting pictures on Facebook, online dating sites and the increasingly prevalent use of video chat technology like Skype and FaceTime make it harder to hide a person’s least favorite feature or perceived flaws, said Dr. Malcolm Roth, president of the American Society of Plastic Surgeons and the head of plastic surgery at Albany Medical Center in New York. “We tend to not look at what we don’t like,” said Roth. “I think there is a heightened awareness to how we look to the outside world.”   The surgery is even appealing to people out of work, according to Roth, who said the cost hasn’t deterred some who say it gives them more confidence at job interviews. Chin augmentation can be done by putting a semi-solid implant on top of the chin, by moving bone to reconstruct the chin or simply by using a needle and syringe for an injection to enhance the chin, Roth said. The procedure leaves minimal scarring from a very small incision and is sometimes coupled with micro-liposuction to trim a so-called double chin, enhancing the neck and jaw line even further. Recuperation is easy and patients can typically be back to normal routines in a matter of days, Roth said. Despite the chin implant boom, breast augmentation still reigns as the most popular cosmetic procedure. The surgery costs about $10,000 more than 307,000 procedures were performed in 2011, statistics showed. Antell said he expects the chin implants trend to continue, largely because of the quick recovery and low complication rate. He added that other similar, smaller scale procedures at a younger age are also likely to climb. “This is an operation that whispers, it doesn’t shout,” said Antell. “Most people are not looking for huge changes, they are just hoping to look a little better, the best they can.” Claim: Best face forward: chin implants surge in popularity.
[A]:
Over the last year Dr. Darrick Antell has performed up to three or four chin implants a day, reflecting a national trend that has seen chin augmentations emerge as the fastest growing plastic surgery trend of 2011.